Xue-Yan Zhang Selected Research

Xue-Yan Zhang Research Topics

Disease

18	Neoplasms (Cancer) 05/2024 - 12/2000
7	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2004
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 06/2004
3	Adenocarcinoma of Lung 01/2022 - 06/2004
3	Neoplasm Metastasis (Metastasis) 03/2020 - 12/2011
2	Primitive Neuroectodermal Tumors (PNET) 03/2020 - 01/2020
1	Fibrosis (Cirrhosis) 04/2022
1	Huntington Disease (Huntington's Disease) 12/2021
1	COVID-19 07/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2020
1	Lymphatic Metastasis 03/2020
1	Gouty Arthritis 01/2019
1	Edema (Dropsy) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2018
1	Intrahepatic Cholestasis 11/2017
1	Inflammation (Inflammations) 11/2017
1	Myxoma (Myxomas) 10/2015
1	Infections 09/2015
1	Type 2 Diabetes Mellitus (MODY) 08/2014
1	Diabetes Mellitus 08/2014
1	Facial Paralysis (Facial Palsy) 07/2009
1	Enteritis 07/2009
1	Lymphoma (Lymphomas) 07/2006
1	T-Cell Lymphoma (Lymphoma, T Cell) 07/2006
1	Carcinoma (Carcinomatosis) 12/2000

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2003
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2010
2	Long Noncoding RNAIBA 05/2024 - 01/2022
2	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 11/2018
2	Docetaxel (Taxotere)FDA Link 01/2021 - 01/2020
2	atezolizumabIBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 07/2006 - 12/2000
1	Protein Isoforms (Isoforms)IBA 12/2022
1	Blood Glucose (Blood Sugar)IBA 04/2022
1	LipidsIBA 04/2022
1	Kaurane DiterpenesIBA 12/2020
1	DiterpenesIBA 12/2020
1	ciclesonide FDA Link 07/2020
1	Niclosamide FDA Link 07/2020
1	Chloroquine (Aralen)FDA LinkGeneric 07/2020
1	remdesivirIBA 07/2020
1	B7-H1 AntigenIBA 07/2020
1	Programmed Cell Death 1 ReceptorIBA 07/2020
1	Tumor Biomarkers (Tumor Markers)IBA 03/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	CarbohydratesIBA 01/2020
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2020
1	apatinibIBA 01/2019
1	Angiogenesis InhibitorsIBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Gefitinib (Iressa)FDA Link 01/2019
1	PowdersIBA 11/2017
1	Bile Acids and Salts (Bile Acids)IBA 11/2017
1	isothiocyanic acidIBA 11/2017
1	EnzymesIBA 08/2015
1	ImmunosorbentsIBA 08/2015
1	Culture MediaIBA 08/2015
1	C-Reactive ProteinIBA 08/2015
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 08/2015
1	Insulin (Novolin)FDA Link 08/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 08/2014
1	Insulin Glargine (Lantus)FDA Link 08/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2013
1	ORALIT (ORS)IBA 12/2013
1	UteroglobinIBA 12/2010
1	muskIBA 07/2009
1	A-factor (Streptomyces)IBA 07/2006
1	Transcription Factors (Transcription Factor)IBA 07/2006
1	Complementary DNA (cDNA)IBA 07/2006
1	RNA (Ribonucleic Acid)IBA 07/2006
1	Gemcitabine FDA Link 06/2004
1	Therapeutic UsesIBA 12/2000
1	5-bromo-4-chloro-3-indolyl beta-galactoside (X-gal)IBA 12/2000
1	Coloring Agents (Dyes)IBA 12/2000

Therapy/Procedure

2	Therapeutics 05/2024 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
1	Extracorporeal Membrane Oxygenation 07/2020
1	Immunotherapy 07/2020
1	Palliative Care (Palliative Therapy) 10/2015
1	Oral Hygiene (Dental Hygiene) 09/2015
1	Operative Surgical Procedures 12/2011
1	Lymph Node Excision (Lymph Node Dissection) 12/2011
1	Meridians (Jing Luo) 07/2009
1	Investigational Therapies (Experimental Therapy) 12/2000